Robert G. Shawah
CIK: 0001601121
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACXP
Acurx Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Shawah Robert G.
Shawah Robert G. (SEC CIK 0001601121) files insider reports with the SEC as Chief Financial Officer of Acurx Pharmaceuticals, Inc. (ACXP).
Signal8 holds 2 ownership filings by Shawah Robert G., all Form 4s, filed between Feb 6, 2025 and Apr 22, 2026. Those filings report 2 transactions, from Feb 5, 2025 to Apr 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Shawah Robert G.'s filings is in STATEN ISLAND, NY.
Recent filings by Shawah Robert G.
Other insiders filing for Acurx Pharmaceuticals, Inc. (ACXP)
- Sailer Carl, Director
- DEAN JACK H, Director
- Donohue James J., Director
- HARRISON THOMAS L, Director
- Scodari Joseph C, Director
- DELUCCIA ROBERT J, Director